Innovation Pharmaceuticals Brilacidin Received by U.S. Regional Biocontainment Laboratory; Testing Against Coronavirus (COVID-19)
March 09, 2020 08:00 ET
|
Innovation Pharmaceuticals Inc.
WAKEFIELD, Mass., March 09, 2020 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, announces today the Company has been...
Innovation Pharmaceuticals Signs Second MTA to Explore Brilacidin as Coronavirus COVID-19 Treatment
March 06, 2020 09:15 ET
|
Innovation Pharmaceuticals Inc.
WAKEFIELD, Mass., March 06, 2020 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage pharmaceutical company, continues to receive inquiries regarding the...
Dynavax Announces Collaboration with the University of Queensland and the Coalition for Epidemic Preparedness (CEPI) Focused on the Development of a Coronavirus (COVID-19) Vaccine
March 02, 2020 08:00 ET
|
Dynavax Technologies Corporation
EMERYVILLE, Calif., March 02, 2020 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, today...
Innovation Pharmaceuticals Provides Scientific Rationale and Clinical Development Perspectives for Brilacidin as a Potential Novel Coronavirus COVID-19 Treatment
March 02, 2020 07:00 ET
|
Innovation Pharmaceuticals Inc.
WAKEFIELD, Mass., March 02, 2020 (GLOBE NEWSWIRE) -- March 2, 2020 (GLOBE NEWSWIRE) Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to...
Only 16% of US Physicians Believe the US Government is Taking Strong Precautions to Prevent the Spread of the Coronavirus, According to Wave 2 of InCrowd’s COVID-19 Tracking Report
February 28, 2020 11:22 ET
|
InCrowd, Inc
WATERTOWN, Mass., Feb. 28, 2020 (GLOBE NEWSWIRE) -- New data on US physician sentiment about the preparedness of the US healthcare system for the novel coronavirus (COVID-19) showed a decline in...
Resilience360 Annual Risk Report Reveals Impacts of 2019 Supply Chain Disruptions and Predicts 2020 Supply Chain Risks
February 27, 2020 09:27 ET
|
Resilience360
TROISDORF, Germany, Feb. 27, 2020 (GLOBE NEWSWIRE) -- The annual Risk Report from supply chain risk management platform Resilience360 summarizes the significant supply chain challenges of the last...
Innovation Pharmaceuticals to Ship Brilacidin to U.S. Regional Biocontainment Laboratory for Research Against Coronavirus COVID-19
February 27, 2020 08:31 ET
|
Innovation Pharmaceuticals Inc.
WAKEFIELD, Mass., Feb. 27, 2020 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, announced today the Company signed a Material...
US Physicians Aren’t Confident About US Coronavirus Preparedness, According to InCrowd Data
February 13, 2020 08:00 ET
|
InCrowd, Inc
WATERTOWN, Mass., Feb. 13, 2020 (GLOBE NEWSWIRE) -- As the number of US novel coronavirus (now named COVID-19) cases increase, US physicians report a lack of confidence in their preparedness to...
Flu Activity at “High Levels” Nationwide as Americans Stress About Coronavirus
January 30, 2020 08:15 ET
|
Families Fighting Flu
Arlington, Virginia, Jan. 30, 2020 (GLOBE NEWSWIRE) -- The Centers for Disease Control and Prevention (CDC) has confirmed five cases of Coronavirus in the U.S. as of January 29, 2020, while there...
Hemispherx Biopharma Exploring Possible Research Programs in Zika Virus Modeled on a Prior Alferon® N Clinical Trial on Closely Related Flavivirus (West Nile)
February 09, 2016 08:30 ET
|
AIM ImmunoTech Inc.
PHILADELPHIA, Feb. 09, 2016 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) announced today that it is beginning to consider study designs for potential tests of the activity and...